Moreover, the result is congruous with earlier observations that linked the downregulation of FOXO3 with the advancement of renal cell carcinoma (45), gastric cancer (46), and breast cancer (47, 48). Here, FOXO3 is linked to hereditary clear cell renal cell carcinoma.